Douglas Roblin to Drug Therapy, Combination
This is a "connection" page, showing publications Douglas Roblin has written about Drug Therapy, Combination.
Connection Strength
0.088
-
Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics. J Manag Care Pharm. 2003 Jan-Feb; 9(1):29-35.
Score: 0.054
-
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):55-64.
Score: 0.018
-
Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. Respir Med. 2006 Apr; 100(4):595-609.
Score: 0.016